Dong-Wook Kim and colleagues at Yonsei University in Seoul, South Korea, have used genome editing techniques to insert a corrected version of the FVIII gene into stem cells derived from a patient with severe hemophilia A. When these cells differentiated into the cells lining blood vessels they were able to produce and secrete active FVIII protein. The gene discussed is F8; the disease is hemophilia A.